Malaria poses a critical challenge to global health, linking parasitic infection complexities with climate change and public health inequities. The mosquito-transmitted infectious disease is caused by protozoan parasites of the Plasmodium genus, with P falciparum responsible for the most severe cases. This disease spreads through the bite of an infected mosquito, introducing the parasite into the human bloodstream. The significant presence of malaria in Africa is attributed to the Anopheles mosquitoes' long lifespan and preference for biting humans.1
“Parasites are as complex, you can think of them as being as complex as a human cell. Because they code for 1000s of proteins, as opposed to viruses, which only have a minimal genome, they make only a handful of proteins,” Prakash Srinivasan, PhD, assistant professor, Johns Hopkins Malaria Research Institute said. “So, parasites are a lot more complex than viruses. And the reason why it becomes such a big challenge to develop vaccines against parasites, such as the malaria parasite plasmodium.”
Climate Change's Impact on Malaria
Malaria remains a burden in sub-Saharan Africa, further exacerbated by climate change. Fluctuations in temperature and precipitation influence the disease's vectors and incidence rates (IR). A study in BioMed Central outlines how average temperature changes affect malaria incidence rates in nine sub-Saharan countries, noting a 20–80% decrease from 2000 to 2018. Malaria remains a significant public health concern in sub-Saharan Africa, despite a marked decline in incidence rates observed in most of the countries studied.2
This study aligns with recent findings, showing a 20–80% decrease in malaria IR from 2000 to 2018. However, there's significant variability in IR, with high rates in Uganda, Mozambique, Nigeria, and Zambia; moderate in Ghana, Zimbabwe, and Kenya; and low in South Africa and Ethiopia in 2018. It highlights how IR varies with average temperature changes in some countries and points out an inverse temperature-IR relationship, especially during periods of IR decrease in Ghana and Nigeria that matched with temperature increases. These decreasing IR trends, affected by temperature fluctuations, are likely shaped by intervention efforts and rainfall changes. Yet, the threat of vulnerability and changing climate may challenge further reductions in malaria IR.
“Malaria represents an emblematic example of how climate change can directly influence human health, facilitating the spread of infectious diseases previously confined to well-defined geographical areas,” Mariana Torres, MD, head of surveillance at BlueDot said. “Responding to this challenge requires a coordinated approach that includes environmental monitoring, vector control, research and development of new diagnostic and therapeutic tools, and public information and awareness campaigns.”
Main Takeaways
- Malaria is caused by Plasmodium parasites, with P falciparum leading to the most severe cases.
- Climate change influences malaria transmission patterns, with fluctuations in temperature and precipitation affecting vector behavior and disease incidence rates.
- The WHO has approved two malaria vaccines, RTS,S (Mosquirix) and R21 (Matrix-M), marking significant progress in the fight against malaria.
- Effective malaria control also relies on vector control measures, such as insecticide-treated nets and indoor residual spraying, and the early diagnosis and treatment of cases.
- Combating malaria requires a coordinated global and local effort, including environmental monitoring, research, and development of new tools, public information campaigns, and international cooperation.
Symptoms, Prevention, and Recent Advancements
The Centers for Disease Control and Prevention (CDC) monitors malaria as it becomes more prevalent in the US, emphasizing the risk of serious health issues and fatalities if untreated. In 2020, there were 241 million global instances and 627,000 deaths, mostly among young children in sub-Saharan Africa. Symptoms appear 10-15 days post-infection, with early testing crucial to prevent severe health complications.
Symptoms of malaria typically emerge 10-15 days after a bite from an infected mosquito, and early testing is crucial due to the potential for some malaria strains to lead to serious health complications or death. High-risk groups include infants, children under 5, pregnant women, travelers, and individuals with HIV or AIDS. Critical symptoms encompass severe fatigue, loss of consciousness, repeated seizures, breathing difficulties, discolored or bloody urine, yellowing of the skin (jaundice), and unusual bleeding. Immediate medical attention is necessary for those experiencing severe symptoms. Malaria in pregnant women can result in early delivery, stillbirth, or the birth of an underweight infant. Prevention strategies include mosquito bite avoidance and prophylactic medication, while treatments exist to prevent the progression of mild cases.2
Hernán Acosta, MD, Internal Medicine Specialist and Clinical Lead at BlueDot, notes the importance of vector control and early diagnosis in endemic areas, highlighting challenges like insecticide resistance,
“While highly endemic areas focus on vector control as well, they implement insecticide-treated nets and indoor residual spraying as part of disease control and elimination strategies. However, the increase in insecticide resistance among the Anopheles mosquitoes requires urgent action to maintain and improve malaria control efforts,” Acosta said. “Early diagnosis and treatment and preventive chemotherapy are also part of the population-based strategy in endemic areas. The latter focuses on the use of antimalarial medication during pregnancy, infancy, and in children living in high-risk areas per WHO guidelines.”
